Fengze Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Fengze Sun has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Haiqing Ma
Department of Oncology, Heyuan Hospital of Guangdong Provincial People’s Hospital, Heyuan People’s Hospital, Heyuan, China
1 shared publication Huanhuan Sun
Department of Oncology, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China
1 shared publicationJianjun Tang
Department of Gastroenterology, Cancer Hospital of Jiangxi Province, Nanchang, Jiangxi, China
1 shared publicationShuncong Wang
Department of Oncology, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China
1 shared publicationXiangqiong Mo
Department of Gastrointestinal Surgery, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China
1 shared publicationYifeng Liao
Department of Oncology, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China
1 shared publication
Latest Publications
- 6 February 2018
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 33 (4) , 837-846
Increased survival rates in gastric cancer, with a narrowing gender gap and widening socioeconomic status gap: A period analysis from 1984 to 2013
Background and Aim: Gastric cancer (GC) has the fifth highest incidence rate of all cancers and has a poor prognosis. However, no recent large‐scale and long‐term studies have evaluated the incidence and survival rates of individuals with GC.Methods: In order to explore the change of GC incidence and survival rates by age, gender, race, and socioeconomic status (SES), incidence data and survival status of patients with GC between 1984 and 2013 were abstracted from the Surveillance, Epidemiology, and End Results database. Totally, 87 242 cases of GC were exported and were analyzed.Results: During these three decades, the incidence of GC was 7.4, 6.8, and 5.5 per 100 000 individuals in each decade. The 1‐year relative survival rates (RSRs) improved from 42.4% to 44.3% to 49.0% (P < 0.0001), with a larger increase seen in the third decade. However, the long‐term survival rates remained low (from 17.8% to 20.3% to 22.9% for the 5‐year RSRs, P < 0.0001; from 14.1% to 16.4% to 18.6% for the 10‐year RSRs, P < 0.0001).Conclusion: Our analysis demonstrated the decreased incidence and increased survival rate of GC. In addition, lower SES was associated with lower survival rates. It is notable that others (primarily for Asians) had the highest incidence rate but had better outcomes than Whites and Blacks.
- 6 February 2018
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 33 (4) , 837-846
Increased survival rates in gastric cancer, with a narrowing gender gap and widening socioeconomic status gap: A period analysis from 1984 to 2013
Background and Aim: Gastric cancer (GC) has the fifth highest incidence rate of all cancers and has a poor prognosis. However, no recent large‐scale and long‐term studies have evaluated the incidence and survival rates of individuals with GC.Methods: In order to explore the change of GC incidence and survival rates by age, gender, race, and socioeconomic status (SES), incidence data and survival status of patients with GC between 1984 and 2013 were abstracted from the Surveillance, Epidemiology, and End Results database. Totally, 87 242 cases of GC were exported and were analyzed.Results: During these three decades, the incidence of GC was 7.4, 6.8, and 5.5 per 100 000 individuals in each decade. The 1‐year relative survival rates (RSRs) improved from 42.4% to 44.3% to 49.0% (P < 0.0001), with a larger increase seen in the third decade. However, the long‐term survival rates remained low (from 17.8% to 20.3% to 22.9% for the 5‐year RSRs, P < 0.0001; from 14.1% to 16.4% to 18.6% for the 10‐year RSRs, P < 0.0001).Conclusion: Our analysis demonstrated the decreased incidence and increased survival rate of GC. In addition, lower SES was associated with lower survival rates. It is notable that others (primarily for Asians) had the highest incidence rate but had better outcomes than Whites and Blacks.